INTRODUCTION Print Section Listen Historically termed “carcinoid” and “islet cell tumors,” pancreatic neuroendocrine tumors (PNETs) comprise a rare group of tumors that range from the spectrum of well-differentiated functional tumors…
BACKGROUND Print Section Listen Cushing’s syndrome describes the signs and symptoms associated with prolonged exposure to elevated levels of endogenous or exogenous glucocorticoids. This can be caused by taking glucocorticoid…
BACKGROUND Print Section Listen There has been a significant steady increase in the number of thyroid surgeries performed annually in the United States,1 escalating existing pressures to maintain a low…
INTRODUCTION Print Section Listen Insulinomas are relatively rare tumors of the endocrine pancreas that cause debilitating and even life-threatening symptoms. Although insulinomas are rare, with an incidence of approximately 4…
INTRODUCTION Print Section Listen Thyroid malignancies are classified on the basis of the origin of cells into medullary thyroid cancer (MTC), which originates from the parafollicular cells, and nonmedullary thyroid…
BACKGROUND Print Section Listen Lymphoma, though primarily a neoplasm of leukocytes, can involve extranodal, nonlymphoid tissue including the thyroid. When the thyroid is involved by widely disseminated lymphoma, the surgeon…
BACKGROUND Print Section Listen Pheochromocytomas (PCCs) and paragangliomas (PGLs) arise from chromafin cells originating in the neural crest, and can develop in any location containing sympathetic or parasympathetic tissue. Although…
BACKGROUND Print Section Listen It was not until the 19th century that Billroth, Kocher, Halsted, and others refined the thyroidectomy operation into a standard treatment for thyroid cancer with advancements…
BACKGROUND Print Section Listen Adrenocortical carcinoma (ACC) is a rare but often aggressive endocrine malignancy that may present with symptoms of hormone secretion, as a symptomatic nonfunctional abdominal mass, or…
BACKGROUND Print Section Listen Hürthle cell carcinoma is a rare subtype of well-differentiated thyroid cancer representing 3% to 4% of all thyroid malignancies.1 First described by Max Askanazy in 1898…
